NewsRoom Articles - Page 190 of 219

MondayDec 07, 2020 12:00 pm

President Putin Orders Coronavirus Vaccination to Begin

President Vladimir Putin of Russia has ordered that health officials in the country begin coronavirus vaccinations next week. The country has manufactured about 2 million doses of its vaccine. President Putin’s statement was made on the same day that Britain gave its seal of approval for the BioNTech-Pfizer vaccine to be made available to the public, also starting next week. In the previous week, the country produced provisional test results of the Sputnik V vaccine that showed that it was more than 95% effective. The vaccine was developed by the National Research Center for Epidemiology and Microbiology. The vaccine is…

FridayDec 04, 2020 12:32 pm

Brain Scientific Inc. (BRSF) Well Positioned Within Growing EEG Equipment Market

Recent report estimates EEG equipment market will grow at 4.5% CAGR reaching $1.99 billion by 2026 Driving forces include aging population, technological advances, increased use in neonatal intensive care units BRSF well-placed to capitalize on market's robust growth A recent report published by Allied Market Research estimates that the global electroencephalography (“EEG”) equipment market was $1.4 billion in 2018 and is expected to reach $1.99 billion by 2026, growing at a CAGR of 4.5% from 2019 to 2026 (https://ibn.fm/Jmxjq). As a commercial-stage, healthcare company dedicated to developing innovative medical devices in the neurological diagnostics space, Brain Scientific (OTCQB: BRSF) seems well…

FridayDec 04, 2020 11:00 am

University of Delaware Receives $11 Million NIH Research Grant

The National Institutes of Health extended the COBRE grant valued at over $11 million for the University of Delaware biomedical research team. This will allow the team to proceed to phase 2 of their research. The Center of Biomedical Research Excellence grant is centered on finding therapeutic leads and chemical probes. The research team is led by Professor Joseph Fox, a professor in the Department of Engineering and Materials Science as well as the Department of Biochemistry and Chemistry. The team of researchers who were awarded the grant are focused on discovering new molecules that can be utilized in studying…

ThursdayDec 03, 2020 12:00 pm

Risks Associated with Prolonged Sitting Can Be Counteracted by Engaging in Physical Activity

Recent guidelines introduced by the World Health Organization (WHO) on sedentary behavior and physical activity show that indulging in weekly physical activities can neutralize the health harms linked to prolonged sitting. These guidelines were reported in as special issue of “British Journal of Sports Medicine.” The article notes that all physical activity is good for a person’s health in the long term. This is the first time that such recommendations have been made, which indicates that there’s growing evidence that connects a sedentary lifestyle to grave ill health and an increased risk of early death. Data that was released last…

WednesdayDec 02, 2020 11:00 am

Researchers Find That Hypertension Increases Brain Damage Risk with Age

A research study conducted by Centre for Prevention of Stroke and Dementia clinical research fellow Dr. Karolina Wartolowska investigated the presence of white matter hyperintensities in the brain. These hyperintensities usually highlight small blood vessels that may be damaged and that manifest on MRI scans as bright regions. This damage is said to increase with blood pressure and age; the damage is linked to a decrease in cognitive function and an increased risk of depression, physical disabilities, dementia and stroke. The study involved 37,041 individuals enrolled in the UK Biobank. A huge chunk of the participants was recruited from the…

TuesdayDec 01, 2020 2:37 pm

CNS Pharmaceuticals (NASDAQ: CNSP) Advances Brain Cancer Drug Candidate and Sponsors Annual SNO Conference

Biotechnology developer CNS Pharmaceuticals is preparing, with its partner WPD Pharmaceuticals, a global set of Phase 2 trials for its drug candidate Berubicin, which has shown promise in combating the effectively fatal glioblastoma multiforme (“GBM”) brain cancer Since another company conducted Phase 1 safety trials for Berubicin 14 years ago, one patient has survived cancer-free while two others saw reductions in tumor size of up to 80 percent The Phase 2 trials will build on the Phase 1 results, conducting targeted testing that offers side-by-side comparison between Berubicin and chemotherapy drug lomustine in real time beginning next year The company…

TuesdayDec 01, 2020 12:00 pm

Researchers Create Portable, Low-Cost MRI Scanner

If you’ve ever had to get a scan to assess for head trauma, then you probably had an MRI. The immobile and costly procedure is also used to detect brain cancer. To help make this diagnostic option more accessible, a group of scientists led by researchers from the Massachusetts General Hospital has created a portable, compact, low-cost MRI scanner. This scanner can be located in a doctor’s office or small clinics or installed in an ambulance. The portability of this power head only scanner also allows it to be wheeled into the ward or a patient’s room. This innovation was…

MondayNov 30, 2020 2:47 pm

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Positive Preclinical Data for Potential Anxiety Treatment

VTGN CEO “even more excited about PH94B's potential to change lives without the risky side effects and safety concerns of benzos” Study results suggest PH94B's mechanism of action may not have benzodiazepine-like side effects, such as sedation, cognitive impairment or abuse liability Company making significant progress in preparing PH94B for launch of pivotal Phase 3 study for acute treatment of anxiety in adults with social anxiety disorder VistaGen Therapeutics (NASDAQ: VTGN) has reported new preclinical findings differentiating the mechanism of action of PH94B from that of benzodiazepines (https://ibn.fm/Al4ur). PH94B is an intranasal neuroactive steroid VistaGen is preparing for Phase 3 development…

MondayNov 30, 2020 11:00 am

Psychologist Explains Reason Behind Reckless Behavior Amid Worsening Pandemic

In the last month, COVID-19 cases have increased significantly in New Jersey and Pennsylvania. The recent numbers top the figures recorded during the first wave of the coronavirus when the pandemic first hit. The rising numbers isn’t the most puzzling factor about this; more puzzling may be the fact that, despite the rising cases, people continue to make plans to meet up with family and friends during the upcoming Thanksgiving holiday, instead of social distancing. To help contain the contagion, officials in Philadelphia introduced restrictions last week that limited the number of people in outdoor gatherings and closed museums, gyms…

WednesdayNov 25, 2020 11:00 am

Predictive Oncology’s (NASDAQ: POAI) Skyline Medical Sells 15 Streamway(R) Systems in Q3 2020 as COVID-era Drives Need for Sanitation Systems

Closed design of Streamway(R) System provides safety from potential hazards of drips and spills during endoscopy, radiology, cystoscopy, urology procedures The Streamway(R) System reduces costs, minimizes environmental impact of 50 million potentially disease-infected canisters disposed into landfills POAI’s Skyline Medical sells 8 Streamway(R) Systems to large university hospital in Virginia, 15 sold halfway into Q3 2020 In the age of COVID-19, the need for sanitation and safety during hospital procedures has reached an all-time high. Health professionals have reported an inhibited level of performance due to a lack of protection, comfort, and increased fatigue during surgery (https://ibn.fm/87UEr). Sanitary disposal systems,…